We generated a new monoclonal antibody (MAb), F7.2.38, by immunizing mice w
ith CD3 epsilon gamma delta /CD3 omega complexes purified from human T-cell
s by OKT3 MAb-Sepharose affinity chromatography. Immunoprecipitation experi
ments and Western blotting analysis showed that MAb F7.2.38 recognized the
CD3 epsilon chain in CD3 epsilon cDNA-transfected FOX B-cells and in Variou
s T-cell lines. Using flow cytometry on permeabilized or intact cells, the
epitope was found to be located in the cytoplasmic tail of the CD3 epsilon
chain. Immunohistochemical staining on paraffin-embedded sections showed th
at the reactivity of MAb F7.2.38 was comparable to that of the commercially
available anti-CD3 epsilon polyclonal antibody. Of the 52 well-characteriz
ed T-cell lymphomas, 41 were positive for F7.2.38 (79%), whereas all 37 B-c
ell lymphomas and 69 non-lymphoid tumors were unreactive. This new antiCD3
epsilon antibody would be particularly useful for phenotyping T-cell lympho
mas on routinely processed paraffin-embedded tissue sections.